TrialInternational journal of chronic obstructive pulmonary disease

A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study.

Sverre Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.